Skip to main content
logo
McKesson Corporation (MCK)
NYSE: MCK · Real-Time Price · USD
885.32
-8.07 (-0.90%)
Aug 31, 2026, 4:00 PM EDT - Market closed

McKesson Financials Overview

Millions USD. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal QuarterQ1 2027Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Revenue
105,38096,295106,158103,15097,82790,82395,29493,65179,28376,35580,89877,21574,48368,91070,49070,15767,15466,10268,61466,576
Revenue Growth
7.72%6.02%11.40%10.14%23.39%18.95%17.79%21.29%6.44%10.80%14.77%10.06%10.91%4.25%2.73%5.38%7.15%11.77%9.61%9.49%
Gross Profit
3,6854,0443,6703,5423,2793,3743,2533,2483,0623,5613,1292,9902,9042,9373,1743,0953,0233,2723,4283,352
Operating Income
1,4212,1271,6401,4171,2721,2421,2255421,0611,3961,1518981,0069731,1281,1221,0261,0301,2021,115
Net Income
6141,6821,1861,1107841,2608792419157915896649587871,079926768368-7267
Earnings Per Share
5.1513.739.598.926.2510.016.951.877.006.014.424.927.025.697.666.425.262.46-0.051.71
EPS Growth
-17.60%37.18%37.99%377.00%-10.71%66.36%57.24%-61.99%-0.29%5.62%-42.28%-23.34%33.37%131.27%-275.34%71.40%-40.57%--51.70%

Revenue by Segment
Chart
Fiscal QuarterQ1 2027Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
North American Pharmaceutical
86,77379,12088,32286,48182,72976,94381,19880,01866,348-----------
Oncology & Multispecialty
14,22212,71113,01012,04410,6589,4319,4939,1578,781-----------
Prescription Technology Solutions
1,5661,4951,5001,3761,4341,3391,3711,2651,2411,1801,2051,1401,2441,1821,1211,0181,0661,0201,031932
Medical Surgical Solutions
2,8192,8682,9912,9472,7012,8532,9492,9462,6322,8373,0312,8342,6112,6892,9862,8432,5922,8743,0823,124
Other Segment
-101335302305257283265281-----------
Revenue (Total)
105,38096,295106,158103,15097,82790,82395,29493,65179,28376,35580,89877,21574,48368,91070,49070,15767,15466,10268,61466,576

Cash & Debt
Chart
Fiscal QuarterQ1 2027Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Cash & Investments
5,1643,9752,9594,0042,4185,6911,1312,5092,3024,5831,9822,5242,6364,6782,7742,9162,2333,5632,7542,151
Total Debt
11,7968,7868,7359,95510,1967,4329,7907,2557,4367,4267,6407,3687,4767,3138,2227,3087,4327,6178,0998,048
Net Cash (Debt)
-6,632-4,811-5,776-5,951-7,778-1,741-8,659-4,746-5,134-2,843-5,658-4,844-4,840-2,635-5,448-4,392-5,199-4,054-5,345-5,897
Net Cash Growth
--------------------
Net Cash Per Share
-55.64-39.21-46.69-47.84-61.98-13.83-68.40-36.71-39.28-21.60-42.45-35.93-35.43-19.09-38.64-30.48-35.63-27.17-35.26-37.85

Cash Flow & CapEx
Chart
Fiscal QuarterQ1 2027Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Operating Cash Flow
-2203,4211,2322,420-9187,748-2,3832,100-1,3804,147254965-1,0523,3251,6681,107-9412,8871,3771,792
Capital Expenditures
-112-111-108-106-111-169-126-136-106-188-90-75-78-125-108-86-71-135-67-93
Free Cash Flow
-3323,3101,1242,314-1,0297,579-2,5091,964-1,4863,959164890-1,1303,2001,5601,021-1,0122,7521,3101,699
Free Cash Flow Growth
--56.33%-17.82%-91.44%-120.67%-23.72%-89.49%-12.83%-16.28%19.08%-39.91%--14.32%19.74%84.88%

Margins
Chart
Fiscal QuarterQ1 2027Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Gross Margin
3.50%4.20%3.46%3.43%3.35%3.72%3.41%3.47%3.86%4.66%3.87%3.87%3.90%4.26%4.50%4.41%4.50%4.95%5.00%5.04%
Operating Margin
1.35%2.21%1.54%1.37%1.30%1.37%1.29%0.58%1.34%1.83%1.42%1.16%1.35%1.41%1.60%1.60%1.53%1.56%1.75%1.68%
Pretax Margin
1.24%2.21%1.54%1.35%1.07%1.67%1.29%0.57%1.37%1.53%0.76%1.19%1.46%1.35%2.05%1.77%1.50%0.98%0.40%0.66%
Profit Margin
0.58%1.75%1.12%1.08%0.80%1.39%0.92%0.26%1.15%1.04%0.73%0.86%1.29%1.14%1.53%1.32%1.14%0.56%-0.01%0.40%
FCF Margin
-0.32%3.44%1.06%2.24%-1.05%8.34%-2.63%2.10%-1.87%5.18%0.20%1.15%-1.52%4.64%2.21%1.46%-1.51%4.16%1.91%2.55%

Dividends
Chart
Fiscal QuarterQ1 2027Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Dividend Per Share
0.8200.8200.8200.8200.7100.7100.7100.7100.6200.6200.6200.6200.5400.5400.5400.5400.4700.4700.4700.470
Dividend Per Share Growth
15.49%15.49%15.49%15.49%14.52%14.52%14.52%14.52%14.82%14.82%14.82%14.82%14.89%14.89%14.89%14.89%11.91%11.91%11.91%11.91%
Dividend Yield
0.43%0.37%0.37%0.38%0.39%0.41%0.47%0.52%0.43%0.45%0.51%0.52%0.51%0.60%0.55%0.58%0.59%0.61%0.73%0.89%

Valuation
Chart
Fiscal QuarterQ1 2027Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
PE Ratio
19.2722.2623.3323.8328.9325.6025.6025.2825.6023.5020.5516.8215.4413.7016.9323.7733.5541.17--
Forward PE
17.0719.9919.9119.4419.6218.4716.4515.3318.4518.4716.2215.9916.0713.5914.8113.8314.0013.4411.4310.17
P/FCF Ratio
-18.5310.1415.12-15.20-13.94-18.1719.7212.98-10.2212.3112.00-11.338.427.19
PS Ratio
0.220.260.250.250.240.240.210.190.240.230.200.200.200.180.190.180.170.170.150.12